Form 4 Tracker
Edwards Lifesciences Corp
EW

53 insider filings · Latest: Aug 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 5, 2024Nov 5 9:11 PMWood Larry L
Proposed Sale
25,000$65.91$1.6M

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 11, 2026Aug 11 9:07 PMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.684,333(D)

View →

Jul 28, 2026Jul 28 11:40 PMWayne MarkowitzCVP, JAPAC
Option Exercise
9,628$74.029,628(D)

View →

Jul 9, 2026Jul 10 9:11 PMTheodora MistrasCVP, Chief Financial Officer
Grant/Award
74,125$91.3312,325(D)

View →

Jul 10, 2026Jul 10 9:04 PMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.684,952(D)

View →

Jun 30, 2026Jul 1 12:01 AMDaniel J. LippisCVP, TAVR
Option Exercise
619$72.685,571(D)

View →

May 18, 2026May 18 9:29 PMDaniel J. LippisCVP, TAVR
Option Exercise
620$72.686,190(D)

View →

May 11, 2026May 12 8:55 PMBernard J ZovighianDirector, CEO
Option Exercise
47,2070(D)

View →

May 11, 2026May 12 8:52 PMDonald E Bobo JRCVP,Strategy/Corp Development
Option Exercise
13,4570(D)

View →

May 11, 2026May 12 8:50 PMDaveen ChopraCVP, TMTT & Surgical
Option Exercise
13,5830(D)

View →

May 11, 2026May 12 1:59 AMScott B. UllemCVP, Chief Financial Officer
Option Exercise
19,8300(D)

View →

May 7, 2026May 12 1:33 AMWayne MarkowitzCVP, JAPAC
Grant/Award
31,600$82.765,200(D)

View →

May 7, 2026May 12 1:32 AMBernard J ZovighianDirector, CEO
Grant/Award
289,100$82.7643,800(D)

View →

May 7, 2026May 9 1:17 AMDonald E Bobo JRCVP,Strategy/Corp Development
Grant/Award
51,850$82.767,850(D)

View →

May 7, 2026May 9 1:16 AMDaniel J. LippisCVP, TAVR
Grant/Award
47,750$82.767,850(D)

View →

May 7, 2026May 9 1:16 AMAndrew M. DahlSVP, Corporate Controller
Grant/Award
6,745$82.766,745(D)

View →

May 7, 2026May 9 1:16 AMDaveen ChopraCVP, TMTT & Surgical
Grant/Award
58,775$82.769,675(D)

View →

May 7, 2026May 9 1:15 AMAnnette BrulsCVP, EMEACLA
Grant/Award
40,350$82.766,650(D)

View →

May 5, 2026May 5 11:08 PMScott B. UllemCVP, Chief Financial Officer
Option Exercise
13,000$59.260(D)

View →

May 4, 2026May 4 11:30 PMDaniel J. LippisCVP, TAVR
Option Exercise
1,019$59.260(D)

View →

May 1, 2026May 4 11:30 PMDaniel J. LippisCVP, TAVR
Option Exercise
1,019$59.261,019(D)

View →

Page 1 of 2

Next →